Cargando…
Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
OBJECTIVE: Lung injury activates multiple pro-inflammatory pathways, including neutrophils, epithelial, and endothelial injury, and coagulation factors leading to acute respiratory distress syndrome (ARDS). Low-dose methylprednisolone therapy (MPT) improved oxygenation and ventilation in early pedia...
Autores principales: | Kimura, Dai, Saravia, Jordy, Rovnaghi, Cynthia R., Meduri, Gianfranco Umberto, Schwingshackl, Andreas, Cormier, Stephania A., Anand, Kanwaljeet J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815896/ https://www.ncbi.nlm.nih.gov/pubmed/27066464 http://dx.doi.org/10.3389/fped.2016.00031 |
Ejemplares similares
-
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
por: Schwingshackl, Andreas, et al.
Publicado: (2016) -
Editorial: ARDS: Reaching for the Horizon
por: McGuire, John K., et al.
Publicado: (2017) -
Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2016) -
Biomarkers in Pediatric ARDS: Future Directions
por: Orwoll, Benjamin E., et al.
Publicado: (2016) -
Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)